Form 4: Amarin Director Diane E. Sullivan Reports Changes in Beneficial Ownership

Director Diane E. Sullivan reports transactions involving Amarin Corp PLC American Depositary Shares, including acquisition and disposal related to vesting of restricted stock units.

Summary

• On April 18, 2025, Director Diane E. Sullivan engaged in transactions involving Amarin Corp PLC's American Depositary Shares (ADS).
• These transactions included the acquisition of 838 ADS related to the vesting of restricted stock units (RSUs).
• Sullivan also disposed of 437 ADS to cover tax liabilities associated with the vesting of these securities at a price of $9.11 per share.
• Following these transactions, Sullivan directly owns 401 ADS and 1,676 RSUs.
• The transactions reflect adjustments due to a ratio change implemented on April 11, 2025, where one ADS now represents twenty Ordinary Shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the filing primarily reports routine transactions related to equity compensation. The vesting of RSUs is a positive sign, but the sale of shares to cover taxes is a neutral event.

Positives

• The vesting of RSUs indicates that performance milestones were likely met, triggering the equity award.

Negatives

• The disposal of shares to cover tax liabilities, while common, slightly reduces the director's holdings in the company.

Risks

• Tax liabilities arising from vesting equity awards could lead to further disposal of shares by the director.

Future Outlook

The director's remaining RSUs will vest in two equal installments on April 18, 2026, and April 18, 2027.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Comparison to Industry Standards

• Form 4 filings are a standard regulatory requirement for publicly traded companies in the US, ensuring transparency regarding insider transactions.
• Similar filings are made by directors and officers of comparable pharmaceutical companies like Pfizer, Novartis, and Johnson & Johnson when they trade their company's stock.
• The transactions reported are typical for equity compensation plans, where shares are often sold to cover tax obligations upon vesting.

Stakeholder Impact

• The transactions provide transparency to shareholders regarding insider activity.
• The disposal of shares to cover tax liabilities has a minimal impact on the overall market.

Next Steps

• The director will have additional RSU vesting events on April 18, 2026, and April 18, 2027.

Key Dates

Keywords

Amarin Corp PLC, Diane E. Sullivan, Beneficial Ownership, Form 4, ADS, RSU, Director, AMRN